Clarke Trafford bought TRAW
December 12, 2025 · Form 4 insider transaction
Clarke Trafford bought 6,157 shares of Traws Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,157
Price
$0.00
Total value
N/A
InsiderClarke Trafford
RoleDirector
CompanyTraws Pharma, Inc. (TRAW)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after6,157
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis.